Rankings
▼
Calendar
FOLD FY 2018 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FOLD
Amicus Therapeutics, Inc.
$5B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$91M
+147.1% YoY
Gross Profit
$77M
84.2% margin
Operating Income
-$329M
-360.3% margin
Net Income
-$349M
-382.5% margin
EPS (Diluted)
$-1.88
Cash Flow
Operating Cash Flow
-$300M
Free Cash Flow
-$306M
Stock-Based Comp.
$29M
Balance Sheet
Total Assets
$790M
Total Liabilities
$447M
Stockholders' Equity
$343M
Cash & Equivalents
$80M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$91M
$37M
+147.1%
Gross Profit
$77M
$31M
+150.3%
Operating Income
-$329M
-$442M
+25.6%
Net Income
-$349M
-$284M
-22.9%
← Q4 2017
All Quarters
Q1 2018 →